WLF Will Use FDA Notice On Circuit Court Ruling As Wedge To Reopen Case
This article was originally published in The Gray Sheet
Executive Summary
FDA's intention to use journal reprints distributed for off-label indications as evidence in misbranding enforcement actions violates the standing injunction on two "enduring materials" guidance documents, the Washington Legal Foundation contends.